Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression and lower transmission rates. The molecular features that could be assigned as directly involved in this in vivo phenotype remain essentially unknown, and th. - Fundacao para a Ciencia e Tecnologia (FCT) [POCI/SAU-IMI/55726/2004]. - Grant sponsor: Fundacao para a Ciencia e Tecnologia (FCT); Grant number: POCI/SAU-IMI/55726/2004
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...
Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression an...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) differ in their pathogenic mechanisms...
AbstractThe chemokine coreceptors play a significant role in HIV entry and pathogenesis. The V3 regi...
HIV-2 is less pathogenic and less transmissible compared to HIV-1. This is believed to be due to the...
Human immunodeficiency virus type 2 (HIV-2) infections cause severe immunodeficiency in humans, alth...
We have previously shown the existence of primary human immunodeficiency virus type 2 isolates (MIC9...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The objective of the study was to assess the genotypic and phenotypic properties of 18 viral strains...
© 2006, American Society for Microbiology. All Rights Reserved.CCR5 expression determines susceptibi...
HIV has killed millions of people since its discovery in the 1980s and continues to be a costly dise...
Background: The HIV-2 env’s 3 ’ end encodes the cytoplasmic tail (CT) of the Env protein. This genom...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...
Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression an...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) differ in their pathogenic mechanisms...
AbstractThe chemokine coreceptors play a significant role in HIV entry and pathogenesis. The V3 regi...
HIV-2 is less pathogenic and less transmissible compared to HIV-1. This is believed to be due to the...
Human immunodeficiency virus type 2 (HIV-2) infections cause severe immunodeficiency in humans, alth...
We have previously shown the existence of primary human immunodeficiency virus type 2 isolates (MIC9...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The objective of the study was to assess the genotypic and phenotypic properties of 18 viral strains...
© 2006, American Society for Microbiology. All Rights Reserved.CCR5 expression determines susceptibi...
HIV has killed millions of people since its discovery in the 1980s and continues to be a costly dise...
Background: The HIV-2 env’s 3 ’ end encodes the cytoplasmic tail (CT) of the Env protein. This genom...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...